Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon Posts President of Proprietary Products | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Patheon Posts President of Proprietary Products

Glass brings more than 17 years of experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Geoff Glass has been appointed president of Patheon’s new Proprietary Products business unit following the Banner Pharmacaps acquisition. Mr. Glass, previously executive vice president of Global Sales and Marketing, has been with the company for four years, overseeing sales and marketing initiatives worldwide. He has more than 17 years of experience in the pharmaceutical industry.

In this newly created role, Mr. Glass he will be primarily responsible for the strategy of the new division, including Rx and commercial products. He will be responsible for the profitability of the business, along with managing all business operations, including R&D and sales and marketing. He will also develop the “how to go to market” strategy, helping to enhance and advance the current business.

“Geoff has played an integral role on Patheon’s leadership team, and I continue to be impressed with his focus on exceeding expectations and driving results. This is an exciting time for Patheon and I am confident in Geoff’s ability and expertise to be able to progress this new business unit forward,” said James C. Mullen, Patheon’s chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters